Type 2 & other diabetes

Predicting incident type 2 diabetes using wearable activity and polygenic risk: A survival-modeling study in All of Us

J Clin Endocrinol MetabPublished Prospective cohort study

Authors' conclusion

Step-count thresholds for reducing T2D risk varied across genetic risk groups, indicating that step counts do not confer uniform protection. Step counts and PRS provided independent, complementary predictive information, and their combination improved prediction of incident T2D.

Study context

Population
Adults in the NIH All of Us Research Program with valid Fitbit step data and whole-genome-derived Polygenic Risk Score (PRS), excluding T2D before or within a 180-day lead-in
Participants
4,589 adults
Exposure
Daily step count and PRS as predictors of incident T2D
Outcome
Incident T2D (HbA1c ≥ 6.5%, plasma glucose ≥126 mg/dL, or All of Us T2D condition record)
Follow-up
Median 2.92 years
Methodological detailssurvival modelling, Cox and machine-learning survival models
  • Survival modelling
  • Cox and machine-learning survival models

Main finding

As reported in the abstract

Incident T2D · median 2.92 years (15 340 person-years)
Participants developing T2D
265
Cumulative incidence
5.77%
Incidence rate
17.27 per 1000 person-years
Per additional 1000 steps/day, aHR
0.83 (95% CI 0.79-0.88; P < .005)
Per 1-SD higher PRS, aHR (2.32-2.96; P < .005)
2.62

Observational data: associations, not effects.

Further findings

Risk-reducing step thresholds

Overall threshold, steps/day (P < .001)
∼7000
High PRS threshold, steps/day
∼7800
Low PRS threshold, steps/day (difference by PRS group P < .001)
∼5800

Discrimination (C-index)

Clinical model
0.748
Clinical model + steps
0.774
Clinical model + steps + PRS
0.867
Penalized Cox (highest)
0.859
Survival support vector machine
0.85
Classical Cox
0.846

Calibration

Calibration was best with Random Survival Forests

Original publication

Predicting incident type 2 diabetes using wearable activity and polygenic risk: A survival-modeling study in All of Us. J Clin Endocrinol Metab. Published 15 December 2025. doi:10.1210/clinem/dgaf673

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.